Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
ZYH7
(2)
Small molecule
Peroxisome proliferator-activated receptor alpha agonist
Unknown
Investigational
Unknown
ZYH7
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BELOTECAN HYDROCHLORIDE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
BELOTECAN HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
01DZ4127G7
Molecule Type:
Small molecule
Molecular Formula:
C25H28ClN3O4
Molecular Weight:
469.97
AlogP:
2.62
PSA:
93.45
HBD:
2.0
HBA:
#RotB:
5.0
Source:
LINAPRAZAN GLURATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
LINAPRAZAN GLURATE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEVOSULPIRIDE
(2)
Small molecule
Dopamine D2 receptor antagonist
Unknown
Investigational
Unknown
LEVOSULPIRIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
JTG7R315LK
Molecule Type:
Small molecule
Molecular Formula:
C15H23N3O4S
Molecular Weight:
341.43
AlogP:
0.56
PSA:
101.73
HBD:
2.0
HBA:
#RotB:
6.0
Source:
PRESATOVIR
(2)
Small molecule
Fusion glycoprotein F0 inhibitor
Unknown
Investigational
Unknown
PRESATOVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
9628AJ27JA
Molecule Type:
Small molecule
Molecular Formula:
C24H30ClN7O3S
Molecular Weight:
532.07
AlogP:
2.97
PSA:
125.93
HBD:
2.0
HBA:
#RotB:
5.0
Source:
PARENT OF TAS-303
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
PARENT OF TAS-303
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OXFENDAZOLE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
OXFENDAZOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
OMP2H17F9E
Molecule Type:
Small molecule
Molecular Formula:
C15H13N3O3S
Molecular Weight:
315.35
AlogP:
2.91
PSA:
84.08
HBD:
2.0
HBA:
#RotB:
3.0
Source:
HEMOGLOBIN RAFFIMER
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
HEMOGLOBIN RAFFIMER
×
Maximum Phase:
2
First Approval:
None
UNII:
69HRT16MGP
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SAPITINIB
(2)
Small molecule
Epidermal growth factor receptor erbB1 inhibitor
Unknown
Investigational
Unknown
SAPITINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
3499328002
Molecule Type:
Small molecule
Molecular Formula:
C23H25ClFN5O3
Molecular Weight:
473.94
AlogP:
3.76
PSA:
88.61
HBD:
2.0
HBA:
#RotB:
7.0
Source:
TALADEGIB
(2)
Small molecule
Smoothened homolog antagonist
Unknown
Investigational
Unknown
TALADEGIB
×
Maximum Phase:
2
First Approval:
None
UNII:
QY8BWX1LJ5
Molecule Type:
Small molecule
Molecular Formula:
C26H24F4N6O
Molecular Weight:
512.51
AlogP:
4.93
PSA:
67.15
HBD:
0.0
HBA:
#RotB:
4.0
Source:
PH-797804
(2)
Small molecule
MAP kinase p38 alpha inhibitor
Unknown
Investigational
Unknown
PH-797804
×
Maximum Phase:
2
First Approval:
None
UNII:
GEL7GRJ3R6
Molecule Type:
Small molecule
Molecular Formula:
C22H19BrF2N2O3
Molecular Weight:
477.31
AlogP:
4.43
PSA:
60.33
HBD:
1.0
HBA:
#RotB:
5.0
Source:
VAMOROLONE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
VAMOROLONE
×
Maximum Phase:
2
First Approval:
None
UNII:
8XP29XMB43
Molecule Type:
Small molecule
Molecular Formula:
C23H30O3
Molecular Weight:
354.49
AlogP:
4.17
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
2.0
Source:
TIDEGLUSIB
(2)
Small molecule
Glycogen synthase kinase-3 beta inhibitor
Unknown
Investigational
Unknown
TIDEGLUSIB
×
Maximum Phase:
2
First Approval:
None
UNII:
Q747Y6TT42
Molecule Type:
Small molecule
Molecular Formula:
C19H14N2O2S
Molecular Weight:
334.4
AlogP:
3.26
PSA:
44.0
HBD:
0.0
HBA:
#RotB:
3.0
Source:
SUVN-G3031
(2)
Small molecule
Histamine H3 receptor inverse agonist
Unknown
Investigational
Unknown
SUVN-G3031
×
Maximum Phase:
2
First Approval:
None
UNII:
65V47O9NOP
Molecule Type:
Small molecule
Molecular Formula:
C21H31N3O3
Molecular Weight:
373.5
AlogP:
2.35
PSA:
54.04
HBD:
1.0
HBA:
#RotB:
6.0
Source:
HYMECROMONE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
HYMECROMONE
×
Maximum Phase:
2
First Approval:
None
UNII:
3T5NG4Q468
Molecule Type:
Small molecule
Molecular Formula:
C10H8O3
Molecular Weight:
176.17
AlogP:
1.81
PSA:
50.44
HBD:
1.0
HBA:
#RotB:
0.0
Source:
AZASETRON
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
AZASETRON
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SOBLIDOTIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
SOBLIDOTIN
×
Maximum Phase:
2
First Approval:
None
UNII:
DQC51A0WQH
Molecule Type:
Small molecule
Molecular Formula:
C39H67N5O6
Molecular Weight:
701.99
AlogP:
3.99
PSA:
120.52
HBD:
2.0
HBA:
#RotB:
20.0
Source:
GW501516
(2)
Small molecule
Peroxisome proliferator-activated receptor delta agonist
Unknown
Approved
Unknown
GW501516
×
Maximum Phase:
2
First Approval:
None
UNII:
7I2HA1NU22
Molecule Type:
Small molecule
Molecular Formula:
C21H18F3NO3S2
Molecular Weight:
453.51
AlogP:
6.2
PSA:
59.42
HBD:
1.0
HBA:
#RotB:
7.0
Source:
EVODENOSON
(2)
Small molecule
Adenosine A2a receptor agonist
Unknown
Investigational
Unknown
EVODENOSON
×
Maximum Phase:
2
First Approval:
None
UNII:
HZ03U10J2Z
Molecule Type:
Small molecule
Molecular Formula:
C23H29N7O6
Molecular Weight:
499.53
AlogP:
-0.47
PSA:
177.95
HBD:
4.0
HBA:
#RotB:
4.0
Source:
DEFACTINIB
(2)
Small molecule
Focal adhesion kinase 1 inhibitor
Unknown
Investigational
Unknown
DEFACTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
53O87HA2QU
Molecule Type:
Small molecule
Molecular Formula:
C20H21F3N8O3S
Molecular Weight:
510.5
AlogP:
2.4
PSA:
142.1
HBD:
3.0
HBA:
#RotB:
8.0
Source:
PF-06291874
(2)
Small molecule
Glucagon receptor antagonist
Unknown
Investigational
Unknown
PF-06291874
×
Maximum Phase:
2
First Approval:
None
UNII:
CGY4I8F278
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NBI-921352
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
NBI-921352
×
Maximum Phase:
2
First Approval:
None
UNII:
SV2WPA4R4J
Molecule Type:
Small molecule
Molecular Formula:
C22H25FN4O2S2
Molecular Weight:
460.6
AlogP:
4.1
PSA:
65.54
HBD:
1.0
HBA:
#RotB:
7.0
Source:
AR9281
(2)
Small molecule
Epoxide hydratase inhibitor
Unknown
Investigational
Unknown
AR9281
×
Maximum Phase:
2
First Approval:
None
UNII:
4HA03Q8EZ9
Molecule Type:
Small molecule
Molecular Formula:
C18H29N3O2
Molecular Weight:
319.45
AlogP:
2.27
PSA:
61.44
HBD:
2.0
HBA:
#RotB:
2.0
Source:
PIBOSEROD
(2)
Small molecule
Serotonin 4 (5-HT4) receptor antagonist
Unknown
Investigational
Unknown
PIBOSEROD
×
Maximum Phase:
2
First Approval:
None
UNII:
4UQ3S81B25
Molecule Type:
Small molecule
Molecular Formula:
C22H31N3O2
Molecular Weight:
369.51
AlogP:
3.67
PSA:
46.5
HBD:
1.0
HBA:
#RotB:
6.0
Source:
PF-00217830
(2)
Small molecule
Dopamine D2 receptor partial agonist
Unknown
Investigational
Unknown
PF-00217830
×
Maximum Phase:
2
First Approval:
None
UNII:
8BC08N1MS5
Molecule Type:
Small molecule
Molecular Formula:
C26H30N4O2
Molecular Weight:
430.55
AlogP:
4.1
PSA:
57.7
HBD:
1.0
HBA:
#RotB:
7.0
Source:
NAFITHROMYCIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
NAFITHROMYCIN
×
Maximum Phase:
2
First Approval:
None
UNII:
75F74Y2R70
Molecule Type:
Small molecule
Molecular Formula:
C42H62N6O11S
Molecular Weight:
859.06
AlogP:
4.12
PSA:
224.18
HBD:
2.0
HBA:
#RotB:
10.0
Source:
ELISMETREP
(2)
Small molecule
Transient receptor potential cation channel subfamily M member 8 inhibitor
Unknown
Investigational
Unknown
ELISMETREP
×
Maximum Phase:
2
First Approval:
None
UNII:
KIB8V5UR7D
Molecule Type:
Small molecule
Molecular Formula:
C27H21F3N2O5S
Molecular Weight:
542.53
AlogP:
6.1
PSA:
96.8
HBD:
1.0
HBA:
#RotB:
8.0
Source:
UBENIMEX
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
UBENIMEX
×
Maximum Phase:
2
First Approval:
None
UNII:
I0J33N5627
Molecule Type:
Small molecule
Molecular Formula:
C16H24N2O4
Molecular Weight:
308.38
AlogP:
0.53
PSA:
112.65
HBD:
4.0
HBA:
#RotB:
8.0
Source:
FIRTECAN PEGOL
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
FIRTECAN PEGOL
×
Maximum Phase:
2
First Approval:
None
UNII:
WC4978T687
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MGB-BP-3
(2)
Small molecule
DNA binding agent
Unknown
Investigational
Unknown
MGB-BP-3
×
Maximum Phase:
2
First Approval:
None
UNII:
532PWU9738
Molecule Type:
Small molecule
Molecular Formula:
C36H37N7O4
Molecular Weight:
631.74
AlogP:
4.65
PSA:
122.52
HBD:
3.0
HBA:
#RotB:
10.0
Source:
TALAROZOLE
(2)
Small molecule
Cytochrome P450 26A1 inhibitor
Unknown
Investigational
Unknown
TALAROZOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
XKD9N5CJ6W
Molecule Type:
Small molecule
Molecular Formula:
C21H23N5S
Molecular Weight:
377.52
AlogP:
5.66
PSA:
55.63
HBD:
1.0
HBA:
#RotB:
7.0
Source:
GALICAFTOR
(2)
Small molecule
Cystic fibrosis transmembrane conductance regulator positive modulator
Unknown
Investigational
Unknown
GALICAFTOR
×
Maximum Phase:
2
First Approval:
None
UNII:
J0IIT8QSQS
Molecule Type:
Small molecule
Molecular Formula:
C28H21F4NO7
Molecular Weight:
559.47
AlogP:
5.72
PSA:
103.32
HBD:
2.0
HBA:
#RotB:
7.0
Source:
LAVOLTIDINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
LAVOLTIDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
X16K5179V5
Molecule Type:
Small molecule
Molecular Formula:
C19H29N5O2
Molecular Weight:
359.47
AlogP:
2.17
PSA:
75.44
HBD:
2.0
HBA:
#RotB:
9.0
Source:
BREQUINAR
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
BREQUINAR
×
Maximum Phase:
2
First Approval:
None
UNII:
5XL19F49H6
Molecule Type:
Small molecule
Molecular Formula:
C23H15F2NO2
Molecular Weight:
375.37
AlogP:
5.85
PSA:
50.19
HBD:
1.0
HBA:
#RotB:
3.0
Source:
DIAZOXIDE CHOLINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
DIAZOXIDE CHOLINE
×
Maximum Phase:
2
First Approval:
None
UNII:
2U8NRZ7P8L
Molecule Type:
Small molecule
Molecular Formula:
C13H20ClN3O3S
Molecular Weight:
333.84
AlogP:
1.87
PSA:
58.53
HBD:
1.0
HBA:
#RotB:
0.0
Source:
L-THREONIC ACID
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
L-THREONIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
75B0PMW2JF
Molecule Type:
Small molecule
Molecular Formula:
C4H8O5
Molecular Weight:
136.1
AlogP:
-2.21
PSA:
97.99
HBD:
4.0
HBA:
#RotB:
3.0
Source:
1
2
…
153
154
155
156
157
158
159
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA